ES75
TEAS SECTION 71 & 15 RECEIVED
06/09/2026
Back to search
Official data from USPTO
PROVEPHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PROVEPHARM
ST13
US500000079275168Class
1, 5
Filing
79275168
Registration
6150137
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
06/10/2026
Trademark type
Word
Nice classes
1, 5
Filing date
10/30/2019
Registration date
09/15/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/15/2020
Last transaction
06/10/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
33
Owner location
FR
Examiner
MCCLELLAN, MATTHEW D.
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PROVEPHARM LIFE SOLUTIONS
Representatives
Aaron Y. Silverstein Saunders & Silverstein LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical products in the nature of bulk powderschemical intermediate for the synthesis of pharmaceutical active substances for use in industryin science; Chemical preparations in the nature of methylene blue for scientific or research use; chemical products for use in manufacture of medicines; raw proteins for scientific and medical research; proteins used in manufacturing processes; chemical productsemulsifiersvitaminsantioxidantsadditivesemollients and proteins for manufacture of cosmetics
Class 5
Pharmaceutical and sanitary products and preparations for medical purposesfor human and animal health; chemical preparations in the nature of methylene blue for medical use; chemical preparations in the nature of methylene blue solutions for medical use; medicines for the treatment of blood poisoning; Medicines used as a contrast solution for scintigraphic imaging procedures; medicines for medical diagnostic purposes for viewing and marking tissue; medicines for the detection of fistulas and leaks during surgical procedures; medicines for tissue staining; medicines for the detection of the sentinel lymph node; medicines for conducting visceral surgery; clinical medical reagents; Synthetic peptides for pharmaceutical usefor cancer treatmentsimmunotherapycell therapyantivirals and antibiotics; medicines for animals; vitamins for animals; foamsoilslotionscreamsbalmslotionsointmentsgels and milks for pharmaceuticalmedical or veterinary use; phytotherapy preparations for medical use
Publications
History of USPTO decisions and trademark events.
26 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/15/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/23/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/31/2020
FIMP
FINAL DISPOSITION PROCESSED
12/31/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/15/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/15/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/30/2020
PUBO
PUBLISHED FOR OPPOSITION
06/30/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/10/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/26/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/25/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/25/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/25/2020
RFNT
REFUSAL PROCESSED BY IB
04/10/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/25/2020
RFRR
REFUSAL PROCESSED BY MPU
03/25/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/06/2020
CNRT
NON-FINAL ACTION WRITTEN
03/05/2020
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
03/04/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/12/2020
CNRT
NON-FINAL ACTION WRITTEN
02/11/2020
DOCK
ASSIGNED TO EXAMINER
02/04/2020
MAFR
APPLICATION FILING RECEIPT MAILED
01/10/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/06/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/26/2019
Continuous trademark protection
Get notified about every new filing that threatens PROVEPHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.